4th Quarter - Report

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Firm
Client
Income
—
Expenses
$3,189,666
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 5371; Continuing Appropriations and Extension Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid S. 927; Protecting Pharmacies in Medicaid Act S. 882; Patients Before Middlemen Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

LobbyistCovered position, as disclosed
ANTHONY BUSH —
JONATHAN M HEAFITZ —
LUCIA LEBENS —
JUAN CARLOS SCOTT —
EMILY THREADGILL —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4317 (119th), S. 882 (119th), H.R. 6609 (119th), S. 927 (119th), S. 3345 (119th), H.R. 5371 (119th)

Health Issues HCR

H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

LobbyistCovered position, as disclosed
ANTHONY BUSH —
JONATHAN M HEAFITZ —
LUCIA LEBENS —
JUAN CARLOS SCOTT —
EMILY THREADGILL —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 927 (119th), H.R. 6609 (119th), H.R. 2214 (119th), H.R. 5371 (119th), S. 3345 (119th), H.R. 4317 (119th), S. 3264 (119th), H.R. 6610 (119th), S. 882 (119th), H.R. 3164 (119th), S. 3389 (119th)

Pharmacy PHA

H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

LobbyistCovered position, as disclosed
ANTHONY BUSH —
JONATHAN M HEAFITZ —
LUCIA LEBENS —
JUAN CARLOS SCOTT —
EMILY THREADGILL —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3164 (119th), S. 882 (119th), H.R. 4317 (119th), S. 526 (119th), H.R. 5371 (119th), H.R. 6610 (119th), S. 927 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.